Maze Therapeutics became the latest drug developer to list in New York on Friday, with its shares rising nearly 1% in their debut, giving the company a valuation of $690.37 million.
Although copper wiring is found extensively in electric generating equipment, when it comes to investing, you can think of the metal as the anti-utility. While utilities are considered ...
Crypto is jumping hurdles on the way to February’s bull run onset. Therefore, finding the next big cryptocurrency is the million-dollar question on everyone’s m ...
Small-cap stocks appear riskier after interest rates in the bond market recently spiked, with the Russell 2000 index now in correction territory. The Russell 2000 index RUT, a broad gauge of ...